back to US directory
us clinical guidance

Acute pancreatitis

The 2024 ACG pathway for diagnosis, early severity assessment, fluids, feeding, biliary intervention and pancreatic-necrosis management.

JurisdictionUnited States
Source check2026-08-20
Clinical reviewiatroX editorial team · Clinical editorial review · reviewed 2026-08-20 · due 2027-08-20
AudienceUnited States healthcare professionals
This is an iatroX educational summary of named United States sources, not an official guideline. It does not replace the complete source documents, local policy, specialist advice or clinical judgement. Use the named authority, current FDA labeling, applicable state law, payer rules and local protocol where relevant.

Scope of this summary

Adults with acute pancreatitis diagnosed by compatible pain, pancreatic enzyme elevation or characteristic imaging, with at least two of those three criteria. The 2024 ACG guideline informs early care and complications; pediatric disease, pregnancy and chronic pancreatitis require separate guidance.
sources for this section:acg-acute-pancreatitis-2024

The Bottom Line

  • Diagnose acute pancreatitis from two of three features—characteristic abdominal pain, amylase or lipase more than three times the upper limit of normal, or characteristic imaging—rather than an isolated mild enzyme elevation.
  • Use transabdominal ultrasound to investigate biliary cause and reserve early CT for diagnostic uncertainty or failure to improve after 48–72 hours, rather than routinely scanning every patient at arrival.
  • Provide moderately aggressive isotonic crystalloid resuscitation, preferring lactated Ringer solution, with frequent reassessment during the first hours to avoid both hypoperfusion and fluid overload.
  • Start early oral low-fat solid feeding in mild disease as tolerated and use enteral rather than parenteral nutrition in more severe disease when oral intake is not possible.
  • Do not give prophylactic antibiotics for sterile necrosis; use ERCP within 24 hours for pancreatitis complicated by cholangitis, while avoiding urgent ERCP in biliary pancreatitis without cholangitis or persistent obstruction.
sources for this section:acg-acute-pancreatitis-2024

Practical clinical workflow

1
Assess pain, vital signs, oxygenation, urine output, mental state and volume status; obtain lipase, blood count, metabolic and liver panels, calcium and triglycerides when the cause is not clear.
2
Identify gallstones, alcohol, hypertriglyceridemia, medication, recent ERCP and less common causes; obtain ultrasound and consider a pancreatic tumor in an unexplained episode after age 40.
3
Begin monitored lactated Ringer resuscitation, analgesia and antiemetic care, then reassess blood urea nitrogen, hematocrit, cardiopulmonary status and urine output within hours rather than using a fixed fluid volume.
4
Feed early as tolerated, provide enteral tube feeding when needed and monitor for persistent organ failure, local complications and infection; involve higher-level care for severe physiology.
5
Arrange same-admission cholecystectomy for mild acute biliary pancreatitis when appropriate, and delay intervention for stable pancreatic necrosis—usually four to six weeks—when the patient can be managed safely.
sources for this section:acg-acute-pancreatitis-2024

Safety boundaries and escalation

  • Shock, hypoxemia, acute kidney injury, altered mental status, rising lactate or persistent organ failure requires intensive monitoring and multidisciplinary acute care.
  • New sepsis or clinical deterioration after the first week can indicate infected necrosis, cholangitis or another infection and needs imaging, cultures and specialist source control rather than prophylactic antibiotics.
  • Aggressive fluid without reassessment can worsen respiratory failure or abdominal compartment physiology, especially in cardiac or renal disease.
  • Do not perform fine-needle aspiration routinely for suspected infected necrosis and do not intervene early in stable sterile necrosis solely because a collection is visible.
sources for this section:acg-acute-pancreatitis-2024asge-choledocholithiasis-2019

Localization

Use the 2024 ACG guideline together with local critical-care, interventional endoscopy, radiology and pancreatic-surgery capability. US product labeling and hospital protocols govern drugs and nutrition.
sources for this section:acg-acute-pancreatitis-2024

Source documents

Use the linked source documents for complete recommendations, evidence grading, exclusions and implementation detail.

  1. American College of GastroenterologyAmerican College of Gastroenterology Guidelines: Management of Acute PancreatitisDOI 10.14309/ajg.0000000000002645 · published 2024-03-01 · accessed 2026-08-20
    view source
  2. American Society for Gastrointestinal EndoscopyASGE guideline on the role of endoscopy in the evaluation and management of choledocholithiasisDOI 10.1016/j.gie.2018.10.001 · published 2019-06-01 · accessed 2026-08-20
    view source
continue the learning

From guidance to deliberate practice and evidence

Choose what happens next. iatroX can carry this page's jurisdiction, source-check date and released version into an editable learning record, support your reflection, or let you browse the regional question bank while keeping this topic visible. No action records completion, starts a session or awards CPD/CME credit automatically.

Add this guidance review to CPD/CMEOpen an editable learning-log record with this page’s provenance attached. You confirm the activity, time, reflection and mappings.Reflect on this with TutorUse optional prompts to consider what you learned and what—if anything—you may change. Suggestions are never inserted automatically.Browse the US question bankKeep this guidance topic in view, then choose your exam and filters. No session starts automatically.
Found a source update or regional discrepancy? Tell the iatroX editorial team.